Lobbying client
CANCERCARE
cancer patient support and advocacy
Filings
5
Filed by
1
Reported in-house
—
Reported by firms
$45,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2025 to 2026
Filings
3 filings for 2025, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Report 4th Quarter 2025
|
PATTERSON & MEEK | $15,000 reported |
|
3rd Quarter - Amendment 3rd Quarter 2025
|
PATTERSON & MEEK | — reported |
|
Registration 3rd Quarter 2025
|
PATTERSON & MEEK | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| PATTERSON & MEEK | 4 | $45,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Insurance | INS | 5 |
| Health Issues | HCR | 1 |
| Medicare/Medicaid | MMM | 1 |
| Pharmacy | PHA | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.